Floatz logo

IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER

Lymphocytic Neoplasm

M.D. Anderson Cancer Centermonoclonal_antibodyPhase 2Dormant
B
63/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
48/ 100
Competitive Position
95/ 100

Competitive context

6 Active assets in the Lymphocytic Neoplasm cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
Case Comprehensive Cancer Center
Phase 2BB
ETOPOSIDE
M.D. Anderson Cancer Center
Phase 2BB
Abt-263
AbbVie
Phase 1/2B
Fludarabine
M.D. Anderson Cancer Center
Phase 2B
FILGRASTIM
M.D. Anderson Cancer Center
Phase 2B

View all 33 →

Same molecule, other indications

IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER is also rated in:

Recurrent Adult Burkitt LymphomaDormant
BBB
Indicative ·
78 / 100
View asset →
Recurrent Adult Diffuse Small Cleaved Cell LymphomaDormant
BBB
Indicative ·
76 / 100
View asset →
lymphoblastic lymphomaDormant
BBB
Indicative ·
75 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →